NEW YORK, Sept 29 – Chipmaker Ciphergen Biosystems (Nasdaq: CIPH) showed a gain of 100 percent on its first day of trading while bioinformatics company Genomica (Nasdaq: GNOM) gained only 2 percent.

Winton Gibbons, genomics analyst at William Blair, said, “Ciphergen’s strength reflects proteomics as being one of the important major investment areas in the post-genomic era. The fact that Genomica is relatively flat reflects that it’s difficult for a bioinformatics company to attract attention without proprietary content, even though its software is good.”